Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bradley Louis Radoff currently holds 27,861 shares of OptimizeRx Corp (OPRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bradley Louis Radoff has been a net seller of OPRX stock. They have purchased $3.8M and sold $17.1M worth of shares.
Bradley Louis Radoff's most recent insider trade was on Dec 9, 2025, when they sold 27,861 shares at $3.23 per share.
Bradley Louis Radoff serves as Executive at OptimizeRx Corp (OPRX). They have executed 82 insider transactions totaling $20.9M over their tenure at the company.
Bradley Louis Radoff holds the position of Executive at OptimizeRx Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Bradley Louis Radoff has shown a selling trading pattern, with $3.8M in total purchases and $17.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Bradley Louis Radoff was on Aug 16, 2022, when they sold $5.1M worth of HHS shares. This transaction involved 333,502 shares at $15.17 per share.
Bradley Louis Radoff currently owns 27,861 shares of OptimizeRx Corp (OPRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bradley Louis Radoff's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bradley Louis Radoff has 82 Form 4 filings on record as an insider at OptimizeRx Corp.
Set alerts for Bradley Louis Radoff and 40,000+ other insiders.